| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | — | 2 | — | — | 8 | 1 | — | 3 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 3.86 |
—
—
—
|
| 2025 | 3.65 |
—
—
—
—
|
| 2024 | 3.45 |
—
—
—
—
|
| 2023 | 3.28 |
—
—
—
—
|
| 2022 | 3.06 |
—
—
—
—
|
| 2021 | 2.85 |
—
—
—
—
|
| 2020 | 2.65 |
—
—
—
—
|
| 2019 | 1.80 |
—
—
—
—
—
|
| 2018 | 2.22 |
—
—
—
—
|
| 2017 | 2.04 |
—
—
—
—
|
| 2016 | 1.88 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 316.10 | 435.50 | 1,122.70 | 266.10 |
| Receivables | 3,761.70 | 3,795.30 | 3,872.40 | 4,029.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 4,077.80 | 4,230.80 | 4,995.10 | 4,295.10 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 10,474.90 | 10,782.20 | 11,240.80 | 11,526.40 |
| ST’ Debt | — | 61.80 | 375.00 | 50.10 |
| Other | — | — | — | — |
| 10,474.90 | 10,844.00 | 11,615.80 | 11,576.50 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,701.40 | 1,726.20 | — | — |
—
|
| ’25 | 1,603.20 | 1,654.40 | 1,665.00 | 1,671.80 |
6,594.40
|
| ’24 | 1,551.10 | 1,536.70 | 1,565.30 | 1,584.30 |
6,237.40
|
| ’23 | 1,443.70 | 1,504.40 | 1,516.60 | 1,528.80 |
5,993.50
|
| ’22 | 1,330.70 | 1,292.90 | 1,366.30 | 1,478.70 |
5,468.60
|
| ’21 | 1,282.10 | 1,292.30 | 1,274.90 | 1,378.50 |
5,227.80
|
| ’20 | 1,056.20 | 1,224.30 | 1,249.80 | 1,294.50 |
4,824.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 118.80 | 212.30 | — | — |
—
|
| ’25 | 38.90 | 206.60 | 554.40 | 378.20 |
1,178.10
|
| ’24 | 58.70 | 139.50 | 394.70 | 213.50 |
806.40
|
| ’23 | 18.10 | 26.20 | 224.70 | 92.70 |
361.70
|
| ’22 | 200.10 | 8.60 | 315.10 | 198.50 |
722.30
|
| ’21 | 141.80 | 167.20 | 286.40 | 228.30 |
823.70
|
| ’20 | 36.60 | 189.20 | 320.80 | 161.00 |
707.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 115.30 | 209.40 | — | — |
—
|
| ’25 | 37.10 | 204.90 | 551.40 | 377.00 |
1,170.40
|
| ’24 | 56.10 | 137.30 | 392.30 | 210.50 |
796.20
|
| ’23 | 14.60 | 22.90 | 221.80 | 90.50 |
349.80
|
| ’22 | 195.20 | 3.60 | 311.10 | 194.60 |
704.50
|
| ’21 | 139.50 | 165.90 | 284.30 | 226.00 |
815.70
|
| ’20 | 33.40 | 184.60 | 316.50 | 158.20 |
692.70
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 5.20 | 5.38 | — | — |
—
|
| ’25 | 3.50 | 4.30 | 4.90 | 5.47 |
18.16
|
| ’24 | 3.18 | 1.12 | 2.80 | 4.59 |
11.70
|
| ’23 | (0.34) | (1.94) | 0.24 | 2.98 |
0.98
|
| ’22 | 2.90 | 0.63 | 0.01 | (0.33) |
3.21
|
| ’21 | 2.51 | 3.52 | 0.94 | 4.53 |
11.49
|
| ’20 | (1.04) | 3.01 | 3.13 | 4.43 |
9.42
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 123.36 | 103.83 | 119.66 | 145.17 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 155.55 | 148.78 | 166.13 | 188.18 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,600 | 4,800 | 4,900 | 4,900 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.19 | 1.25 | 1.27 | 1.35 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,468.60 | 5,993.50 | 6,237.40 | 6,594.40 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.74% | 31.02% | 39.76% | 43.45% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 144.00 | 41.10 | 537.80 | 843.80 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.63% | 0.69% | 8.62% | 12.80% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 116.00 | 35.30 | 426.00 | 662.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.40 | 14.20 | 8.30 | 2.10 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 153.61 | 167.89 | 173.74 | 184.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 3.21 | 0.99 | 11.87 | 18.16 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.29 | 10.13 | 22.46 | 32.91 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.50) | (0.33) | (0.28) | (0.22) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.79 | 9.80 | 22.18 | 32.69 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 65.55 | 69.06 | 79.16 | 99.76 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.60 | 35.70 | 35.90 | 35.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.34 | 126.74 | 13.14 | 10.06 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.88 | 0.73 | 0.89 | 0.99 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.07 | 1.78 | 1.95 | 1.83 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.97 | 0.81 | 0.95 | 1.01 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.55 | 13.88 | 7.41 | 5.67 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 722.30 | 361.70 | 806.40 | 1,178.10 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.80) | (11.90) | (10.20) | (7.70) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 704.50 | 349.80 | 796.20 | 1,170.40 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6,166.20) | (6,397.10) | (6,613.20) | (6,620.70) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 782.40 | 783.20 | 784.10 | 1,218.30 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 477.40 | 467.10 | 348.60 | 95.60 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,333.70 | 2,465.60 | 2,841.80 | 3,571.50 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.82% | 0.25% | 2.85% | 4.11% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.20% | 0.88% | 10.54% | 14.38% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.23% | 1.47% | 16.05% | 20.66% | — | — | — |
ROE
|
The Hanover Insurance Group (THG) has delivered steady revenue growth, rising 54% to $6.24 billion in 2024 from 2016 levels at a 6% CAGR, fueled by premium hikes and solid employee productivity. However, earnings remain volatile, with EBT margins swinging from 10.7% in 2019 to a mere 0.7% in 2023 due to catastrophe claims, loss cost inflation, and pricing pressures—though a sharp rebound to 8.6% in 2024 signals recovery. Cash flows are robust, supporting dividends and buybacks, while a prudent balance sheet features low net debt and improving returns like 16.1% ROE.
Valuation looks compelling at 10-11x forward PE and 0.9x PS, potentially undervalued versus peers if analyst forecasts pan out—with revenue hitting $7.12 billion by 2027 and EPS surging to $17.82. Yet, optimism is tempered by historical cycles, recent insider selling (over $13 million in shares dumped, no buys), and looming risks like escalating cat losses and climate impacts.
THG earns watchlist status for conservative investors, offering 13-20% upside potential but demanding vigilance amid feast-or-famine profits—patience could pay off, but restraint is key.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.